COURTNEY LINTON: Open Payments
NPI 1104094747 · VAN WERT, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$338 in 19 payments from 12 companies in 2025. Trend: 2023 $191 · 2024 $222 · 2025 $338
Food & beverage: $338
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $49 |
| Otsuka America Pharmaceutical, Inc. | 3 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| ABBVIE INC. | 2 | $33 |
| Amgen Inc. | 2 | $32 |
| Novo Nordisk Inc | 2 | $28 |
| Astellas Pharma US Inc | 1 | $25 |
| Exact Sciences Corporation | 1 | $19 |
| Lilly USA, LLC | 1 | $19 |
| Corcept Therapeutics | 1 | $18 |
Products named: CAPLYTA, REXULTI, AIRSUPRA, Veozah, Cologuard Collection Kit, JARDIANCE, UBRELVY, Korlym.
Industry payments across OH — which companies pay providers there.
